PHENYLEPHRINE HYDROCHLORIDE INJECTION USP SOLUTION

Valsts: Kanāda

Valoda: angļu

Klimata pārmaiņas: Health Canada

Nopērc to tagad

Produkta apraksts Produkta apraksts (SPC)
31-08-2020

Aktīvā sastāvdaļa:

PHENYLEPHRINE HYDROCHLORIDE

Pieejams no:

STERIMAX INC

ATĶ kods:

C01CA06

SNN (starptautisko nepatentēto nosaukumu):

PHENYLEPHRINE

Deva:

10MG

Zāļu forma:

SOLUTION

Kompozīcija:

PHENYLEPHRINE HYDROCHLORIDE 10MG

Ievadīšanas:

INTRAMUSCULAR

Vienības iepakojumā:

15G/50G

Receptes veids:

Ethical

Ārstniecības joma:

VASOCONSTRICTORS

Produktu pārskats:

Active ingredient group (AIG) number: 0100662004; AHFS:

Autorizācija statuss:

APPROVED

Autorizācija datums:

2020-09-01

Produkta apraksts

                                _Product Monograph – Phenylephrine Hydrochloride Injection USP _
_Page 1 of 7 _
PRESCRIBING INFORMATION
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
10 mg/ml
For subcutaneous, intramuscular or intravenous injection only
VASOPRESSOR
SteriMax Inc.
2770 Portland Drive
Oakville, Ontario
L6H 6R4
Date of Preparation:
August 31, 2020
CONTROL NO.: 232497
_Product Monograph – Phenylephrine Hydrochloride Injection USP _
_Page 2 of 7 _
PRESCRIBING INFORMATION
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
10 mg/ml
For subcutaneous, intramuscular or intravenous injection only
VASOPRESSOR
WARNING: PHYSICIANS SHOULD COMPLETELY FAMILIARIZE THEMSELVES WITH
THE COMPLETE CONTENTS OF THIS PRESCRIBING INFORMATION BEFORE
PRESCRIBING THIS DRUG.
DESCRIPTION
Phenylephrine Hydrochloride Injection USP is a vasoconstrictor and
pressor drug chemically
related to epinephrine and ephedrine.
PHARMACOLOGY
When applied topically or infiltrated into the tissues, phenylephrine
produces vasoconstriction
that lasts longer than that of epinephrine and ephedrine. Its action
on the heart contrast sharply
with that of epinephrine and ephedrine, in that it slows the heart
rate and increases the stroke
output, inducing no disturbance in the rhythm of the pulse.
In therapeutic doses, it produces little if any stimulation of either
the spinal cord or cerebrum. A
singular advantage of this drug is the fact that repeated injections
produce comparable effects.
INDICATIONS
For the maintenance of blood pressure during spinal and inhalation
anesthesia, and also for
overcoming peripheral vascular failure in shock and shock-like states,
drug-induced hypotension
or hypersensitivity. Employed to overcome paroxysmal supraventricular
tachycardia, to prolong
spinal anesthesia and as a vasoconstrictor in regional anesthesia.
_Product Monograph – Phenylephrine Hydrochloride Injection USP _
_Page 3 of 7 _
PRECAUTIONS
May be contraindicated in patients with hypertension or ventricular
tachycardia or in patients
who are hypersensitive to the drug.
Should be used with extreme c
                                
                                Izlasiet visu dokumentu
                                
                            

Dokumenti citās valodās

Produkta apraksts Produkta apraksts franču 31-08-2020

Meklēt brīdinājumus, kas saistīti ar šo produktu